321 related articles for article (PubMed ID: 24931955)
1. Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests.
Mahler M; Satoh M; Hudson M; Baron M; Chan JY; Chan EK; Wick J; Fritzler MJ;
J Rheumatol; 2014 Jul; 41(7):1334-43. PubMed ID: 24931955
[TBL] [Abstract][Full Text] [Related]
2. Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay.
Mahler M; Gascon C; Patel S; Ceribelli A; Fritzler MJ; Swart A; Chan EK; Satoh M
Arthritis Res Ther; 2013 Apr; 15(2):R50. PubMed ID: 23587095
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to a novel Rpp38 (Th/To) derived B-cell epitope are specific for systemic sclerosis and associate with a distinct clinical phenotype.
Koenig M; Bentow C; Satoh M; Fritzler MJ; Senécal JL; Mahler M
Rheumatology (Oxford); 2019 Oct; 58(10):1784-1793. PubMed ID: 31323671
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to the mitochondrial RNA processing (MRP) complex also known as Th/To autoantigen.
Mahler M; Fritzler MJ; Satoh M
Autoimmun Rev; 2015 Mar; 14(3):254-7. PubMed ID: 25462581
[TBL] [Abstract][Full Text] [Related]
5. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
[TBL] [Abstract][Full Text] [Related]
6. What autoantibody tests should become widely available to help scleroderma diagnosis and management?
Muro Y; Sugiura K; Akiyama M
Arthritis Res Ther; 2013 Jul; 15(4):116. PubMed ID: 23856077
[TBL] [Abstract][Full Text] [Related]
7. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
8. Cancer in Systemic Sclerosis: Analysis of Antibodies Against Components of the Th/To Complex.
Mecoli CA; Adler BL; Yang Q; Hummers LK; Rosen A; Casciola-Rosen L; Shah AA
Arthritis Rheumatol; 2021 Feb; 73(2):315-323. PubMed ID: 33241644
[TBL] [Abstract][Full Text] [Related]
9. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
10. Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement: an extended methodological approach.
Van Praet JT; Van Steendam K; Smith V; De Bruyne G; Mimori T; Bonroy C; Elewaut D; Deforce D; De Keyser F
Rheumatology (Oxford); 2011 Jul; 50(7):1302-9. PubMed ID: 21330340
[TBL] [Abstract][Full Text] [Related]
11. The integration of the detection of systemic sclerosis-associated antibodies in a routine laboratory setting: comparison of different strategies.
Bonroy C; Smith V; Van Steendam K; Van Praet J; Deforce D; Devreese K; De Keyser F
Clin Chem Lab Med; 2013 Nov; 51(11):2151-60. PubMed ID: 23863700
[TBL] [Abstract][Full Text] [Related]
12. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives.
Harvey G; Black C; Maddison P; McHugh N
J Rheumatol; 1997 Mar; 24(3):477-84. PubMed ID: 9058652
[TBL] [Abstract][Full Text] [Related]
13. PM-Scl and Th/To in systemic sclerosis: a comparison of different autoantibody assays.
Mecoli CA; Gutierrez-Alamillo L; Yang Q; Sampedro M; Woods A; Hummers LK; Wigley F; Shah AA; Casciola-Rosen L
Clin Rheumatol; 2021 Jul; 40(7):2763-2769. PubMed ID: 33459953
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis.
Hudson M; Pope J; Mahler M; Tatibouet S; Steele R; Baron M; ; Fritzler MJ
Arthritis Res Ther; 2012 Mar; 14(2):R50. PubMed ID: 22394602
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis.
Villalta D; Imbastaro T; Di Giovanni S; Lauriti C; Gabini M; Turi MC; Bizzaro N
Autoimmun Rev; 2012 Dec; 12(2):114-20. PubMed ID: 22776784
[TBL] [Abstract][Full Text] [Related]
16. Optimization and diagnostic performance of a single multiparameter lineblot in the serological workup of systemic sclerosis.
Bonroy C; Van Praet J; Smith V; Van Steendam K; Mimori T; Deschepper E; Deforce D; Devreese K; De Keyser F
J Immunol Methods; 2012 May; 379(1-2):53-60. PubMed ID: 22446156
[TBL] [Abstract][Full Text] [Related]
17. Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.
Mahler M; Swart A; Wu J; Szmyrka-Kaczmarek M; Senécal JL; Troyanov Y; Hanly JG; Fritzler MJ
Lupus; 2016 Jul; 25(8):889-96. PubMed ID: 27252266
[TBL] [Abstract][Full Text] [Related]
18. Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis.
Costa S; Mondini M; Caneparo V; Afeltra A; Airò P; Bellisai F; Faggioli P; Gerli R; Lotzniker M; Meroni PL; Morozzi G; Radice A; Riccieri V; Scarsi M; Sebastiani GD; Sinico RA; Tincani A; Gariglio M; Landolfo S
Rheumatology (Oxford); 2011 Apr; 50(4):674-81. PubMed ID: 21134960
[TBL] [Abstract][Full Text] [Related]
19. Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma.
Maes L; Blockmans D; Verschueren P; Westhovens R; De Beéck KO; Vermeersch P; Van den Bergh K; Burlingame RW; Mahler M; Bossuyt X
Clin Chim Acta; 2010 Jul; 411(13-14):965-71. PubMed ID: 20346932
[TBL] [Abstract][Full Text] [Related]
20. Anti-th/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis.
Fischer A; Pfalzgraf FJ; Feghali-Bostwick CA; Wright TM; Curran-Everett D; West SG; Brown KK
J Rheumatol; 2006 Aug; 33(8):1600-5. PubMed ID: 16783860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
